Zimmermann Martine insider trades
Zimmermann Martine has filed 8 Form 4s with the SEC that we hold, for Ligand Pharmaceuticals INC (LGND) (Director) and Candel Therapeutics, Inc. (CADL) (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $342.0K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($342.0K). The largest single trade was a sale of 1,200 shares of Ligand Pharmaceuticals INC worth $342.0K, dated 2026-09-10. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2023-09-26 and the latest 2026-09-24.
Ligand Pharmaceuticals INC (LGND)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-09-10 | S, sale reported on Form 4 | 1,200 | $342.0K | 2026-09-14 |
Candel Therapeutics, Inc. (CADL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1994049) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms